Trump RX Initiative: Coverage for GLP-1 Obesity Drugs from Novo Nordisk and Eli Lilly
November 6, 2025
In a significant policy development, President Donald Trump announced on November 6, 2025, groundbreaking agreements with pharmaceutical giants Eli Lilly and Novo Nordisk to reduce… Read More →